Eyman Partners
  • About Us
    • Our Mission
    • Our Vision
    • Our Story
    • Our Team
      • About Barbara
      • About Sarah
      • About Eva
      • About Sandra
      • About Morgan
      • About Lauren
  • Our Practice
    • Our Practice
    • Our Clients
    • Our Services
  • Resources
    • Medicaid Managed Care
    • 340B Drug Discount Program
    • Medicaid DSH
    • COVID-19 Resources
  • News and Updates
  • Contact
  • Privacy Policy
Select Page

Hospitals appeal dismissal of lawsuit challenging Medicare rate reduction for 340B drugs.

Jan 9, 2018 | 340B, Litigation, News and Updates

On January 9, 2018, hospital groups filed an appeal to the D.C. District Court’s decision granting HHS’ motion to dismiss the lawsuit on Medicare rate reduction for 340B drugs.

2018: New Year, Ongoing Health Policy Challenges

Jan 8, 2018 | Medicaid, News and Updates

Happy New Year from Eyman Partners to our clients and friends. The holiday break has given us a chance to pause and reflect on the year just finished and the challenges ahead. We wanted to share a few of our thoughts on issues we know are of concern to you, as they...

Estimated Cost of 5-Year CHIP Extension Lowered from $8 billion to $800 million

Jan 5, 2018 | Legislation, Medicaid, News and Updates

The Congressional Budget Office lowered its estimate of the costs of extending CHIP for five years under S. 1827 from $8 billion to $800 million due to the repeal of the Affordable Care Act’s individual mandate.

Judge Denies Motion for Preliminary Injunction in 340B Litigation

Dec 29, 2017 | 340B, Litigation, News and Updates

On December 29, 2017, Judge Rudolph Contreras of the DC District Court issued an order in the recent 340B program litigation, granting CMS’ Motion to Dismiss and denying provider-plaintiff’s’ Motion for Preliminary Injunction. This ruling authorizes CMS to move...

CMS Sends Letter to States on Phase-out of Special Federal Funding Mechanism in 1115 Waivers

Dec 15, 2017 | Medicaid, News and Updates, Waivers

On December 15, 2017, CMS notified state Medicaid directors that it will no longer accept state 1115 demonstration proposals that rely on funding for “Designated State Health Programs” (DSHP). While the agency acknowledged that federal DSHP funds were...
« Older Entries
Next Entries »
Categories
  • 340B
  • ACA
  • Analysis
  • COVID-19
  • Directed Payments
  • DSH
  • Executive Action
  • Fraud and Abuse
  • GME
  • Guide
  • Legislation
  • Litigation
  • Medicaid
  • Medicaid DSH
  • Medicaid Managed Care
  • Medicaid Managed Page
  • Medicare
  • News and Updates
  • Resources
  • Rulemaking
  • Uncategorized
  • Waivers
Eyeman Partners logo

Attorney advertising. Prior results do not guarantee a similar outcome.

300 New Jersey Avenue NW, Suite 300
Washington, DC 20001

For Inquiries Please Contact:
Tim Kuhn, Director of Operations

(202) 567-6201

Tkuhn@eymanlaw.com

©2026 © 2025 Eyman Partners | All Rights Reserved | Website by my content co. | Privacy Policy. Web Design by My Content Company